Comparing Your Weight Management Treatment Options
Can You Change From Wegovy To Mounjaro: UK Stock Availability
Patients asking "can you change from Wegovy to Mounjaro" can feel reassured knowing both treatments are readily available from EverydayMeds' UK stock. Unlike previous supply shortages that affected weight management prescriptions, our reliable supply chain from Novo Nordisk ensures all five Wegovy doses remain in stock and ready for next-day delivery. This availability means your prescriber can focus on clinical suitability rather than stock concerns when considering whether to switch treatments.
The decision to change from Wegovy to Mounjaro typically involves clinical factors such as treatment response, side effect profiles, or dosing preferences. Mounjaro's dual GIP/GLP-1 mechanism offers a different approach compared to Wegovy's GLP-1-only action, giving prescribers flexibility in tailoring your weight management strategy. Both prescription-only medicines require ongoing clinical supervision and work alongside a reduced-calorie diet and increased physical activity as part of a comprehensive treatment plan.
Wegovy Pricing Structure and Bundle Options
Understanding the cost implications when you change from Wegovy to Mounjaro helps inform your treatment decision. Wegovy single pens start at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers benefit from discount code FIRST40, whilst returning patients use code DOSE25, both applied automatically at checkout to reach these final prices.
Bundle options provide supply convenience for patients committed to Wegovy treatment. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks of dose escalation, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. These bundles ensure treatment continuity without multiple orders, particularly valuable if you're switching from Mounjaro and want assured Wegovy supply during the transition period.
Clinical Evidence: Understanding Your Treatment Options
When considering whether you can change from Wegovy to Mounjaro, reviewing clinical evidence helps contextualise each treatment's profile. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 extension demonstrated sustained weight loss of approximately 15.2% at 2 years, indicating long-term efficacy when treatment continues.
Mounjaro's clinical programme showed different trial designs and populations, making direct comparison inappropriate without clinical context. Your prescriber can evaluate individual trial data alongside your personal response history, side effect tolerance, and treatment goals when discussing potential switches between these prescription-only medicines.
How Wegovy Works Differently From Mounjaro
The fundamental difference affecting whether you can change from Wegovy to Mounjaro lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This single-pathway approach may reduce food cravings by working on brain appetite centres, helping patients feel satisfied with reduced caloric intake. Mounjaro uses tirzepatide, targeting both GIP and GLP-1 receptors in a dual agonist approach that may offer different metabolic effects. Your prescriber will consider these mechanistic differences when evaluating treatment switches, as individual patient responses can vary significantly between single and dual receptor targeting.
Streamlined Ordering Process for Both Treatments
Whether you're switching from Wegovy to Mounjaro or vice versa, EverydayMeds' clinical assessment process remains consistent and efficient. The 3-minute online questionnaire captures your medical history, current medications, previous weight management treatments, and specific reasons for considering a treatment change. Prescriber review typically takes 3 working days, though express 24-hour review is available for urgent clinical needs. Once your prescription is approved, next-day delivery ensures minimal treatment interruption during any switch. Cold-chain temperature-controlled packaging maintains medication integrity from our GPhC-registered pharmacy (#9012878) directly to your door. This seamless process eliminates supply anxiety that might influence your treatment decision.
Storage and Practical Considerations
Storage requirements present a practical advantage when evaluating whether you can change from Wegovy to Mounjaro. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability benefits frequent travellers or patients without reliable refrigeration access during holidays or work trips. Both treatments use pre-filled injection pens - Wegovy's FlexTouch device offers familiar handling for patients experienced with Novo Nordisk products. The mandatory dose escalation schedule for Wegovy (0.25mg through to 2.4mg maintenance over 16 weeks) provides gradual tolerance building that many patients find comfortable when switching from other treatments.
Switching Between Weight Management Treatments in the UK
The question "can you change from Wegovy to Mounjaro" reflects the growing treatment flexibility available to UK patients through specialist weight management services. Unlike switching between medications where immediate substitution might be appropriate, weight management treatments require careful transition planning to maintain therapeutic continuity. Your prescriber will typically consider factors such as your response timeline, side effect experience, and long-term treatment goals when evaluating switches.
Current UK availability of both treatments through EverydayMeds eliminates historical supply constraints that previously limited prescriber choice. This stock security means clinical decisions can focus purely on patient suitability rather than availability concerns. The transition process typically involves completing your current prescription cycle before initiating the alternative treatment, ensuring no therapeutic gap that might affect your weight management progress.
Secure Your Treatment Choice Today
Don't let supply uncertainty influence your weight management decisions - both Wegovy and Mounjaro remain fully stocked and available for immediate prescription through EverydayMeds. Apply discount code FIRST40 (new customers) or DOSE25 (returning patients) during checkout to access our competitive pricing structure starting from £79.99. Our clinical team stands ready to process your assessment and connect you with experienced prescribers who understand the nuances of switching between weight management treatments. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and secure your prescription-only medicine supply today. Take control of your weight management journey with reliable UK stock and expert clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
